Skip to main content
Swedish Orphan Biovitrum logo

Swedish Orphan Biovitrum — Investor Relations & Filings

Ticker · SOBI ISIN · SE0000872095 LEI · 549300124Y3MQI87PT35 ST Manufacturing
Open in API
Filings indexed 892 across all filing types
Latest filing 2012-05-31 Board/Management Inform…
Country SE Sweden
Listing ST SOBI

About Swedish Orphan Biovitrum

https://www.sobi.com/en

Swedish Orphan Biovitrum (Sobi) is a specialized biopharmaceutical company dedicated to developing and delivering innovative treatments for rare and debilitating diseases. The company's primary focus is on the therapeutic areas of haematology and immunology, with a significant legacy and continued leadership in haemophilia care. Sobi addresses the high unmet medical needs of patients by advancing a pipeline of innovative medicines and working to expand patient access globally. The company's mission is to transform the lives of people affected by rare conditions through dedicated research, development, and global collaboration.

Recent filings

Filing Released Lang Actions
Sobi har utnämnt Birgitte Volck till Chief Medical Officer
Board/Management Information Classification · 99% confidence The document is a press release dated May 31, 2012, announcing the appointment of Birgitte Volck as the new Chief Medical Officer (CMO) for Sobi. It details her background, previous roles, and start date. This type of announcement, concerning changes in senior management or the board of directors, directly corresponds to the definition for Board/Management Information (MANG). The document is short and appears to be an official release, not a comprehensive report.
2012-05-31 Swedish
Sobi appoints Birgitte Volck as Chief Medical Officer
Board/Management Information Classification · 98% confidence The document is a press release dated May 31, 2012, announcing the appointment of Birgitte Volck as the new Chief Medical Officer (CMO) and detailing her background and start date. This content directly relates to changes in senior management personnel. Based on the provided definitions, the category 'Board/Management Information' (Code: MANG) is the most appropriate classification for announcements regarding changes in senior management.
2012-05-31 English
Major Shareholding Notification 2012
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding ('Holder: FMR LLC') for Swedish Orphan Biovitrum AB (publ), specifically noting the 'Reason for major shareholding notification Buy' and providing 'Before the transaction' and 'After the transaction' figures, including the resulting percentage of voting rights (5.09%). This structure—reporting changes in significant ownership thresholds—is characteristic of a Major Shareholding Notification. The document explicitly mentions 'major shareholding notification' and tracks ownership percentages crossing a threshold (implied by the structure, though the specific threshold crossed isn't explicitly stated as the trigger, the content is clearly about tracking major holdings). This aligns perfectly with the definition for Major Shareholding Notification (MRQ). The document length is short (3338 chars), but it is the report itself, not an announcement of a report.
2012-05-28 English
Major Shareholding Notification 2012
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage for a specific holder (FMR LLC) in the issuer (Swedish Orphan Biovitrum AB). It explicitly mentions 'Reason for major shareholding notification Buy', tracks the number of shares and voting rights before and after the transaction, and lists the chain of controlling companies and their respective holdings. This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the filing code MRQ.
2012-05-25 English
Sobi : Kommuniké från Swedish Orphan Biovitrums ("Sobi") årsstämma
AGM Information Classification · 99% confidence The document is explicitly titled "Kommuniké från Swedish Orphan Biovitrums ('Sobi') årsstämma" which translates to 'Communiqué from Swedish Orphan Biovitrum's Annual General Meeting (AGM)'. The content details the decisions made by the shareholders regarding the approval of financial statements, discharge of directors, election of board members and auditors, and approval of remuneration guidelines and incentive programs. These are all standard items discussed and voted upon at an AGM. Therefore, the document fits the definition of AGM Information (AGM-R). The document length (3808 chars) is substantial enough to be the actual summary of the meeting, not just a brief announcement of a report.
2012-04-26 Swedish
Sobi:Resolutions from Swedish Orphan Biovitrum's ("Sobi") Annual General Meeting (AGM)
AGM Information Classification · 100% confidence The document explicitly states in the title and content that it contains the 'Resolutions from Swedish Orphan Biovitrum's ("Sobi") Annual General Meeting (AGM)'. It details the outcomes of votes on board elections, remuneration, profit adoption, and incentive programs, which are the core components of AGM proceedings. This directly maps to the AGM Information category.
2012-04-26 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.